Arvix Laboratories · Patient Guide
UmbiGraft™ and Dehydrated Human Amniotic Membrane: A Patient Guide
Updated October 22, 2026
When you read about a human tissue product, it is important to understand what the material is, what the product is specifically authorized for, and what a qualified clinician recommends for your situation. This guide explains the terms around UmbiGraft™ without making treatment or outcome promises.

What is dehydrated human amniotic membrane?
The amniotic membrane is a layer associated with the placenta. A dehydrated human amniotic membrane (dHAM) product is human tissue that has undergone processing and dehydration. Tissue composition, processing, sterility controls, packaging and instructions can differ between products, so the product label and official documentation matter.
What is UmbiGraft™?
Arvix Laboratories describes UmbiGraft™ as a dehydrated human amniotic membrane product. That short description alone does not establish the product’s exact composition, intended use, suitability for a patient, clinical benefit, or regulatory status. Ask Arvix for the current product label and supporting documentation, and discuss them with the treating specialist.
Why product-specific authorization matters
Regulatory authorization applies to a particular product, manufacturer, intended use and conditions. CDSCO’s public approval list includes a sterile dehydrated human amnion-chorion membrane entry for acute and chronic non-healing wounds; that listing is for the specified entry and does not prove that UmbiGraft™ has the same composition, authorization or indication. Verify the current authorization for the exact product before making a decision.
Questions to ask the treating specialist
- What is this product intended to do for my specific condition?
- What is its exact composition and source, and what donor eligibility and infection screening are documented?
- What product-specific authorization, instructions and evidence apply to this intended use?
- What are the alternatives, possible risks, follow-up needs and costs?
- Who will handle and apply the product, and how is traceability maintained?
Do not purchase or use human tissue products for self-treatment. A qualified clinician should assess whether a specific product is appropriate and explain its known risks and alternatives. Be cautious of guaranteed-cure claims, and do not stop existing care without your clinician’s advice.
Brand and copyright
UmbiGraft™ is the product/brand name supplied for this article. © 2026 Arvix Laboratories. All rights reserved for this original article and illustration. The ™ symbol does not mean a trademark registration has been confirmed; copyright protects original creative material, while protection of a brand name is a trademark matter.
For product documentation or current availability, contact Arvix Laboratories. This article is for general awareness only and is not medical advice, a treatment recommendation, or an offer to sell or provide treatment.
